Variants, the J&J Vaccine, VIIT, and more
Organization: Family and Community Medicine University of TorontoOntario Family Physicians
Published: 2021
"We continue our discussion about COVID-19 with a deeper dive into the Variants of Concern, the Johnson & Johnson vaccine, and how to help your patients weigh the risks and benefits of the viral vector vaccines in light of Vaccine Induced Immune Thrombotic Thrombocytopenia (VIIT)." - Variants, the J&J Vaccine, VIIT, and more
Resource Group:
Implementation Tool
Product Type: Webinar
Research and Development
Vaccine Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Webinar
Category:
Vaccine Safety and Development,Research and Development,Vaccine Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Adverse Events Following Immunization (AEFI),Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentResearch and Development
Vaccine Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.